ChromaDex developed the patent-protected ingredient as the first commercially available brand of nicotinamide riboside (NR). NR, the active ingredient in NiaCel, boosts levels of NAD+ (nicotinamide adenine dinucleotide) in cells. A 2013 study found that increased levels of NAD+ helped support healthy aging by stimulating mitochondrial energy production (Cell. 2013 Dec 19;155(7):1624-38).
"We are very excited to offer NIAGEN nicotinamide riboside to our practitioner network through this new, exclusive product launch. NiaCel provides practitioners with a powerful new solution to promote healthy aging in patients," said Paul Jacobson, CEO of Thorne Research. " NIAGEN is one of the most innovative new ingredients developed in the past decade. We are thrilled to partner together with ChromaDex and our practitioner-customer base to enhance patient health with the introduction of NiaCel."